BioNTech’s Bold Gamble: Navigating Losses and Pioneering Cancer Breakthroughs
BioNTech is transitioning from its COVID-19 vaccine success to focus on pioneering cancer treatments using mRNA technology. Despite a significant drop in earnings, BioNTech exceeded analyst expectations, highlighting its resilience…